Preferred Name |
Abatacept |
|
Synonyms |
Immunoconjugate, CTLA4-Ig BMS-188667 Belatacept BMS224818 Orencia LEA29Y CTLA4-Ig Nulojix CTLA4-Fc Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin BMS 224818 CTLA4-Ig Immunoconjugate BMS188667 BMS 188667 CTLA-4-Ig CTLA4 Ig Immunoconjugate Cytotoxic T Lymphocyte-Associated Antigen 4-Immunoglobulin BMS-224818 |
|
Definitions |
A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS. |
|
ID |
http://purl.bioontology.org/ontology/MESH/D000069594 |
|
altLabel |
Immunoconjugate, CTLA4-Ig BMS-188667 Belatacept BMS224818 Orencia LEA29Y CTLA4-Ig Nulojix CTLA4-Fc Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin BMS 224818 CTLA4-Ig Immunoconjugate BMS188667 BMS 188667 CTLA-4-Ig CTLA4 Ig Immunoconjugate Cytotoxic T Lymphocyte-Associated Antigen 4-Immunoglobulin BMS-224818 |
|
AQL |
AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR |
|
cui |
C1619966 C1619962 C1120968 C1700021 C1172366 C0378942 C3160359 C1120969 |
|
DC |
1 |
|
definition |
A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS. |
|
DX |
20160101 |
|
FX |
D060908 |
|
HN |
2016 (2002) |
|
Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000648 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000502 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000187 http://purl.bioontology.org/ontology/MESH/Q000235 http://purl.bioontology.org/ontology/MESH/Q000633 |
|
Inverse of RB |
7D0YB67S97 0 |
|
Inverse of RO | ||
isa |
http://purl.bioontology.org/ontology/MESH/D000082082 |
|
LT |
TRD |
|
Machine permutation |
2016; ABATACEPT was indexed under IMMUNOCONJUGATES 2002-2015 |
|
MDA |
20150701 |
|
MMR |
20200228 |
|
MN |
D12.776.124.790.651.114.580.225 D12.776.377.715.548.114.580.225 |
|
notation |
D000069594 |
|
PA |
D018501 D007166 D000082082 |
|
prefLabel |
Abatacept |
|
RR |
332348-12-6 |
|
TERMUI |
T675375 T675380 T675370 T675376 T675374 T675371 T675373 T000919361 T000880723 T675377 T000880728 T000880726 T000880727 T670174 |
|
TH |
NLM (2012) USAN (2004) INN (19XX) NLM (2006) FDA SRS (2015) |
|
tui |
T116 T129 T121 |
|
subClassOf |